Senseonics (NYSE:SENS) announced that EmblemHealth is now providing coverage for its Eversense continuous glucose monitoring system. Germantown, Md.-based Senseonics said in a news release that the immediately effective decision adds to the number of payers writing the Eversense system into their CGM coverage policies and paying for the healthcare provider’s time for the in-office sensor placement. […]
Patient Monitoring
NIH increases PhysIQ contract to $6.6M
PhysIQ announced today that the National Institutes of Health (NIH) entered into Phase II of a contract for its AI-based COVID-19 biomarker. A Purdue University-affiliated artificial intelligence company, PhysIQ’s AI-based COVID-19 digital biomarker is being developed to address the rapid decompensation of high-risk COVID-19 patients, according to a news release. PhysIQ’s technology’s cloud platform continuously […]
Senseonics announces $50M from stock offering
Senseonics (NYSE:SENS) announced that it entered into securities purchase agreements worth gross proceeds of approximately $50 million. Germantown, Md.-based Senseonics’ purchase agreements are with several healthcare-focused investors, as well as other institutional investors, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
Philips acquires Capsule Technologies and its medical device data tech
Royal Philips (NYSE:PHG) announced today that it agreed to acquire Capsule Technologies in a deal worth $635 million. Andover, Mass.-based Capsule Technologies develops medical device integration and data technologies for hospitals and healthcare organizations. Its offerings include a medical device information platform for integration, vital signs monitoring and clinical surveillance services, according to a news release. […]
Masimo launches iSirona connectivity hub
Masimo (NSDQ:MASI) announced today that it commenced the global launch of the iSirona medical device connectivity hub. Irvine, Calif.-based Masimo’s iSirona hub is designed to maximize interoperability across care, with efficiency in physically connecting up to six medical devices at the bedside and automatically routing the data to the company’s Hospital Automation platform. Masimo Root, a […]
Atlanta company says its pulse oximeter works with all skin tones
Safe Heart USA claims that its pulse oximeter proved to be 100% more accurate than comparable devices in an analysis by the FDA. Atlanta-based Safe Heart’s iOX smartphone pulse oximeter combines hardware and software technology to accommodate individual skin tone and blood flow, according to a news release. The iOX is powered through the audio […]
Philips wins $2.8M from DoD for early COVID-19 detection tech
The U.S Defense Department has selected Royal Philips (NYSE:PHG) and BioIntelliSense to receive nearly $2.8 million. Amsterdam-based Philips (which has its U.S. base in Cambridge, Mass.) was selected by the DoD through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms, according to a news […]
Report: Higher error rate seen in use of pulse oximeters with Black patients
Pulse oximeters, a handy tool to measure oxygenation issues and elevated heart rates, are reportedly more error-prone with Black patients. The New York Times reported that, based on a study that had its findings shared with the New England Journal of Medicine, the devices can provide misleading results in more than one out of 10 […]
Philips to acquire BioTelemetry for $2.47B
Royal Philips (NYSE:PHG) announced today that it agreed to acquire BioTelemetry (NSDQ:BEAT) in a deal worth $2.8 billion. Amsterdam-based Philips is slated to commence a tender offer to acquire all issued and outstanding shares of BioTelemetry for $72 per share, to be paid upon completion. That represents a 16.5% premium to BioTelemetry’s closing price on Dec. 17, […]
CDC and FDA to monitor recipients of Moderna, Pfizer COVID-19 vaccines for Bell’s Palsy
CDC and FDA have committed to monitoring recipients of two COVID-19 vaccines for Bell’s palsy, a type of facial paralysis. FDA, however, concluded that there is insufficient data to determine whether the mRNA-based vaccines from Moderna (NSDQ:MRNA) and Pfizer (NYSE:PFE)/BioNTech (NSDQ:BNTX) are linked to the condition, which is often temporary. Both vaccines use messenger RNA technology, which is […]
Biotronik wins FDA clearance for cardiac monitor sensor
Biotronik today announced FDA clearance of its Vital Data Sensor, designed to identify body temperature increases potentially associated with fever, as part of its new Biomonitor IIIm injectable cardiac monitor (ICM). Biomonitor IIIm contains integrated sensors designed to measure patient activity, heart rate and body temperature. The new sensor gives physicians access to daily reports […]
